Novo gets much-needed lift as Wegovy pill tops Wall Street forecasts
BioPharma DiveKristin JensenNovember 4, 2026
The drug s third-quarter sales numbers came in well above consensus estimates, widening Novo s early edge over Eli Lilly in the latest battleground for weight loss medicines.